COMMUNIQUÉS West-GlobeNewswire

Top Online Pharmacies to Buy Modafinil in the USA with Fast Shipping (2025)
06/05/2025
Looking to buy modafinil in the US without the hassles of long shipping times? Whether you’re a busy professional, student, or someone looking to enhance their cognitive performance and ultimately increase productivity [...]
Save Big in 2025: Buy Modafinil with Bitcoin From the Best Online Pharmacies
06/05/2025
Buying modafinil online with Bitcoin has become popular among nootropic enthusiasts seeking privacy, security, and savings. Cryptocurrencies like Bitcoin offer a fast and anonymous payment method, often with attractive [...]
Modafinil in Australia: Your Guide to Over-the-Counter Purchases in 2025
06/05/2025
Are you curious about how to buy modafinil in Australia in 2025? Whether you're looking for information on over-the-counter (OTC) options or how to order modafinil online without a prescription, this guide has you [...]
Philips delivers on Q1 results, with ongoing order intake growth
06/05/2025
May 6, 2025 Q1 2025 Group performance Group sales EUR 4.1 billion, reflecting a 2% decline in comparable sales growth mainly due to China; slightly ahead of company outlook due to Personal Health growth and royalty [...]
Novaremed Announces Completion of Enrollment in NIH-sponsored Phase 2b Study with Non-opioid NRD.E1 for the Treatment of Chronic Pain Associated with Diabetic Peripheral Neuropathy
06/05/2025
Last patient first visit (LPFV) marks completion of enrollment of 127 adult and elderly patients in the randomized, placebo-controlled trial -- topline data is expected in Q4 2025 This study builds on Phase 2a proof-of- [...]
Roche introduces innovative Elecsys PRO-C3 test to improve precision in evaluating liver fibrosis severity
06/05/2025
Elecsys PRO-C3, used with the ADAPT formula (age, diabetes status, PRO-C3, platelets), assesses liver fibrosis severity – a disease responsible for approximately one in every 25 deaths worldwide 1 The test delivers [...]
argenx to Present at BofA Securities 2025 Health Care Conference
06/05/2025
May 6, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Tim [...]
Coloplast A/S - Announcement no. 04/2025 - Interim Financial Report, H1 2024/25
06/05/2025
Interim financial results, H1 2024/25 1 October 2024 - 31 March 2025 Coloplast delivered 6% organic growth in Q2, impacted by the product recall in Interventional Urology and a softer quarter in Ostomy Care. Q2 EBIT [...]
Three-month interim report (Q1) 2025 (unaudited)
06/05/2025
ALK delivers 12% organic revenue growth with operating profit up 50% in Q1 Q1 results were strong as expected. Revenue increased on double-digit sales growth in all sales regions, including 22% growth in tablet sales. [...]
Ipsen nomme Laura Réveillon au poste de Vice-Présidente Exécutive, Stratégie et Transformation
06/05/2025
PARIS, FRANCE, 6 mai 2025 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, a annoncé aujourd'hui la nomination de Laura Réveillon, PhD, au poste de Vice-Présidente Exécutive, [...]
Ipsen appoints Laura Réveillon as EVP, Strategy & Transformation
06/05/2025
PARIS, FRANCE, 06 May 2025 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty care-driven biopharmaceutical company, announced today the appointment of Laura Réveillon, PhD as EVP, Strategy & Transformation, [...]
Angelini Ventures Co-Leads $45 Million Series B Financing of Nuevocor to Advance Transformative Treatment for Genetic Dilated Cardiomyopathy
06/05/2025
Angelini Ventures marks its first investment in the cardiovascular and gene therapy space – and first in Asia, further diversifying its strong and growing portfolio Rome, Italy - 6 May 2025 – Angelini Ventures, the [...]
Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines
06/05/2025
Exercised options total USD 143.6 million Secures manufacturing and supply of freeze-dried JYNNEOS ® to the U.S. in 2026 COPENHAGEN, Denmark, May 6, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that the [...]
Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc.
06/05/2025
A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke [...]
DrEO Clinic Named Best Hair Transplant Clinic in Mexico for 2025, Leading the Way in Affordable Medical Tourism
05/05/2025
Mexico City, Mexico, May 05, 2025 (GLOBE NEWSWIRE) -- DrEO Clinic has been recognized as the best hair transplant clinic in Mexico for 2025, reinforcing its position at the forefront of hair restoration excellence. The [...]
Evolved Extraction Solutions Announces Strategic Expansion in U.S. Market Amid Industry Shakeup
05/05/2025
Following the closure of ExtractionTek Stainless and Precision Extraction, Evolved emerges as the financially strong, forward-focused partner—with cross-compatible technology, new U.S. leadership, and end-to-end [...]
Solésence Reports Record First Quarter 2025 Financial Results
05/05/2025
First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and [...]
Celldex Presents Histology Data from Phase 2 Study of Barzolvolimab in EoE Supporting Potential of Mast Depleting Agent in this Difficult to Treat Disease
05/05/2025
Phase 2 study fully enrolled; data expected in 2H 2025 HAMPTON, N.J., May 05, 2025 (GLOBE NEWSWIRE) -- Celldex announced today the presentation of histology data from the Company’s ongoing Phase 2 study of barzolvolimab [...]
Editas Medicine to Announce First Quarter 2025 Financial Results and to Participate in Investor Conference in May
05/05/2025
CAMBRIDGE, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that it [...]

Pages